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Abstract Numerous models of molecular evolution have
been formulated to describe the forces that shape sequence
divergence among homologous proteins. These models
have greatly enhanced our understanding of evolutionary
processes. Rarely are such models empirically tested in the
laboratory, and even more rare, are such models exploited
to generate novel molecules useful for synthetic biology.
Here, we experimentally demonstrate that the heterotachy
model of evolution captures signatures of functional
divergence among homologous elongation factors (EFs)
between bacterial EF-Tu and eukaryotic eEF1A. These EFs
are GTPases that participate in protein translation by pre-
senting aminoacylated-tRNAs to the ribosome. Upon
release from the ribosome, the EFs are recharged by
nucleotide exchange factors EF-Ts in bacteria or eEF1B in
eukaryotes. The two nucleotide exchange factors perform
analogous functions despite not being homologous pro-
teins. The heterotachy model was used to identify a set of
sites in eEF1A/EF-Tu associated with eEF1B binding in
eukaryotes and another reciprocal set associated with
EF-Ts binding in bacteria. Introduction of bacterial EF-Tu
residues at these sites into eEF1A protein efficiently
disrupted binding of cognate eEF1B as well as endowed
eEF1A with the novel ability to bind bacterial EF-Ts. We
further demonstrate that eEF1A variants, unlike yeast wild-
type, can function in a reconstituted in vitro bacterial
translation system.
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Models of molecular evolution attempt to capture the manner
by which biological sequences accumulate substitutions
over evolutionary timescales (Whelan and Goldman 2001;
Yang and Rannala 2012). For instance, one well-known
model captures the biological reality that individual sites do
not accept substitutions in a uniform manner—some sites in
a gene sequence evolve slowly while other sites in the same
gene evolve quickly (Felsenstein and Churchill 1996; Yang
1994). In another instance, an individual site can have dif-
ferent substitution rates at different times in a gene’s evo-
lutionary history (Gaucher et al. 2002b). Such site-specific
rate switching was described by Walter Fitch in this very
journal more than 40 years ago to describe a particular
evolutionary-based sequence pattern observed in proteins
(Fitch 1971; Fitch and Markowitz 1970; Miyamoto and Fitch
1995). This model has since been generalized to accommo-
date similar patterns of substitutions and now goes by the
terms heterotachy or Type-I functional divergence. Het-
erotachy specifically describes the observation that a single
site in a gene can be slowly evolving in one portion of a
phylogenetic tree while rapidly evolving in another portion
of the same tree (Abhiman et al. 2006; Da et al. 2002;
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Gaucher et al. 2002b; Gu 2001; Huelsenbeck 2002;
Kolaczkowski and Thornton 2008; Lockhart et al. 1998;
Lopez et al. 2002; Pupko and Galtier 2002; Roure and Phi-
lippe 2011; Siltberg and Liberles 2002; Tuffley and Steel
1998; Wang et al. 2007; Wang et al. 2011; Wu and Susko
2011) (Fig. 1a). This implies that the selective constraints
acting at a single site can be reciprocal. In a similar manner,
reciprocal selective constraints can occur briefly in a gene’s
evolutionary past while later returning to identical con-
straints. Such a pattern results in Conserved-But-Different
(or Type-II functional divergence) whereby rapidly evolving
sites are later constrained to have slower rates (Gu 2001;
Lopez et al. 2002) (Fig. 1b). In total, these patterns have been
observed in numerous gene families. Less clear, however, is
an understanding of the precise selective constraints that
produce these patterns. Some researchers have argued that
patterns of heterotachy arise from either neutral or purifying
selection (Lopez et al. 2002), while others have argued that
such patterns may arise from adaptive selection due to
functional divergence among homologous sequences (Gau-
cher et al. 2002a; Gaucher et al. 2001).
Here we experimentally test whether sites displaying
patterns of heterotachy/Type-I and Type-II may indeed be
responsible for functional divergence among homologous
proteins and whether they can be exploited to engineer
protein function. An elongation factor (EF) gene family was
chosen for experimental assays because previous studies
have computationally predicted that sites displaying het-
erotachy are potentially involved in functional differences
between bacterial and eukaryotic EFs (Gaucher et al. 2002a;
Gaucher et al. 2001). The current study represents the first
time that the heterotachy/Type-I and Type-II models of
molecular evolution have been experimentally tested and is
intended to accompany other experimental studies that tested
models of molecular evolution (Bershtein and Tawfik 2008;
Hillis et al. 1992; Merlo et al. 2007; Woods et al. 2006).
Fig. 1 Signatures of functional divergence and structures of EFs.
a Amino acid sequence pattern of a hypothetical site displaying
heterotachy/Type-I functional divergence when analyzed within a
phylogenetic framework. The selective constraints acting on the site
are reciprocal between the two clades. Dark branches indicate strong
selective constrains while light branches indicate relaxed constraints.
b Amino acid sequence pattern of a hypothetical site displaying Type-
II functional divergence when analyzed within a phylogenetic
framework. The selective constraints acting on the site were briefly
relaxed on an internal branch (light branch) such that one lineage
mutated away from the original amino acid and this replacement was
later fixed (also called Conserved-But-Different, CBD). c Schematic
three-dimensional structures of bacterial EF-Tu (grey) bound to its
nucleotide exchange factor EF-Ts (top, orange) and eukaryotic
eEF1A (grey) bound to its nucleotide exchange factor eEF1B (bottom,
orange). Although EF-Tu/eEF1A are homologous proteins, their
respective exchange factors are not homologous (Color figure online)
c
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EF-Tu in bacteria and eEF1A in eukaryotes are
homologous G-proteins that perform the same overall
function in their respective domains of life. These bio-
molecules shuttle aminoacylated-tRNAs to the ribosome to
participate in protein translation. Guanosine triphosphate
(GTP) is hydrolyzed once the correct codon/anticodon
base-pairing occurs thereby releasing the EF from the
aminoacylated tRNA. The EF/guanosine diphosphate
(GDP) complex is recharged to the active state through
binding to a nucleotide exchange factor that replaces the
spent nucleotide with a new GTP molecule.
Although EFs perform analogous functions in bacteria
and eukaryotes, some particulars of their behaviors differ.
Most notably, the manner by which nucleotide exchange
occurs between bacterial and eukaryotic EFs is not
homologous. Thus, EFs from eukaryotes have evolved a
complementary mechanism of nucleotide exchange using
eEF1B compared to their bacterial counterparts that use
EF-Ts (Fig. 1c).
To determine the role heterotachy plays in carrying a
signature of functional divergence among EFs, we have
replaced residues in the yeast eEF1A with residues from the
E. coli EF-Tu homolog. Sites were selected based on the
strength and directionality of the signature of functional
divergence between bacterial and eukaryotic EFs. The
selection of sites had two objectives. On one hand, we
wanted to determine if heterotachous sites overlap with the
sites that enable the yeast eEF1A to bind its yeast nucleotide
exchange factor - EF sites evolving slowly in eukaryotes but
rapidly in bacteria. On the other hand, we wanted to deter-
mine if sites displaying functional divergence could be
exploited to allow the yeast eEF1A to bind and interact with
the E. coli nucleotide exchange factor - EF sites evolving
rapidly in eukaryotes but slowly in bacteria.
Results
The selection of sites for the two objectives is described
below. First, for both objectives, sites were partitioned by
their posterior probabilities (PP) of heterotachy/Type-I
functional divergence and by rank-order for their signature
of Type-II functional divergence (Gu 2001). Sites were
then clustered into three nested groups: 1) heterotachy/
Type-I sites having PP C90 %, 2) heterotachy/Type-I sites
having PP C80 % and 3) heterotachy/Type-I sites having
PP C80 % plus the top-ranked Type-II sites.
To determine if sites having signatures of functional
divergence overlap with sites that govern eEF1A–eEF1B
interactions, sites from the three groups above were
retained if the distance between any atoms in eEF1A were
within 5 A˚ of any atom in eEF1B. In addition, in order to
be retained, Type-I EF sites had to exhibit a heterotachous
pattern of slow evolution in eukaryotes but rapid evolution
in bacteria. Such a pattern would be consistent with the
notion that a site is slowly evolving in eukaryotes because
it allows eEF1A to interact with eEF1B, whereas the
homologous site in bacteria is rapidly evolving since it
does not govern interactions between EF-Tu and EF-Ts.
These variants are annotated as KnockOut 1 through 3
(KO1, KO2, KO3).
Reciprocally, in order to engineer the ability of
eukaryotic eEF1A to bind to bacterial EF-Ts, sites from the
three nested groups above were retained if the distance
between residues on eEF1A were within 5 A˚ of any residue
on EF-Ts (inferred from the structural alignment of EF-Tu
and eEF1A bound to their respective nucleotide exchange
factors). Type-I sites also had to exhibit a heterotachous
pattern of slow evolution in bacteria but rapid evolution in
eukaryotes. Such a pattern would be consistent with the
notion that a site is slowly evolving in bacteria because it
allows EF-Tu to interact with EF-Ts, whereas the homol-
ogous site in eukaryotes is rapidly evolving since it does
not govern interactions between eEF1A and eEF1B. These
variants are annotated as KnockIn 1 through 3 (KI1, KI2,
KI3). Variants with both the set of KnockOut and KnockIn
amino acid replacements were also synthesized for nested
groups 2 and 3 and are annotated as KnockOut-KnockIn 2
and 3 (KOKI2 and KOKI3). A variant combining Knock-
Out-KnockIn residues from group 1 was not considered.
The eEF1A variants described above, as well as the
native yeast eEF1A protein, were assayed for their abilities
to bind the eukaryotic and bacterial nucleotide exchange
factors (yeast eEF1B and E. coli EF-Ts). Figure 2 shows
that the wild-type eEF1A protein binds eukaryotic eEF1B
efficiently but cannot bind bacterial EF-Ts at a detectable
level.
Figure 2a demonstrates that the KnockOut variants do
indeed have reduced binding to eEF1B. KO1 and KO2 (PP
C90 % heterotachous/Type-I sites and PP C80 % hetero-
tachous/Type-I site, respectively) displayed substantially
diminished ability to bind eEF1B compared to wild-type
eEF1A. This nearly 50 % decrease in binding demonstrates
that sites displaying heterotachous/Type-I patterns are
indeed linked to functional divergence and that sites having
the greatest affect lie in the PP range of 90–100 % but not
80–89 %. The KO3 variant demonstrated that sites dis-
playing Type-II patterns are also responsible for functional
divergence since this variant displayed an additional
decrease in binding to eEF1B compared to KO2.
Figure 2b shows that the KnockIn variants have indeed
acquired the ability to bind bacterial EF-Ts. All three
variants from KI1 to KI3 displayed an incremental increase
in their abilities to bind EF-Ts. This suggests that signals of
functional divergence can vary in strength yet still shape
biomolecular properties and that no single pattern
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Fig. 2 Loss of eukaryotic eEF1B binding and gain of bacterial EF-Ts
binding in eEF1A variants. Binding assays were performed to
measure the capacity of eEF1A variants to bind to bacterial EF-Ts and
eukaryotic eEF1B. Upper bands correspond to eEF1A and variants
while the lower bands correspond to nucleotide exchange factors.
Graphs below each gel image represent the percentage of eEF1A
bound by the nucleotide exchange factor (cyan for EF-Ts and
magenta for eEF1B) and numbers below are the measured percentage
band intensity for the lower (exchange factor) band compared to the
total (exchange factor plus eEF1A band). a KnockOut variants KO1,
KO2, and KO3. Crystal structure of eEF1A (grey) bound to eEF1B
(cream) with the set of eEF1A residues corresponding to the set of
KO3 mutations displayed in magenta. b KnockIn variants KI1, KI2,
and KI3. Crystal structure of eEF1A (grey) superimposed with EF-Ts
(cream) by structural alignment of eEF1A to EF-Tu bound to EF-Ts.
The set of eEF1A residues corresponding to the set of KI3 mutations
are displayed in cyan. c KnockOut-KnockIn variants KOKI2 and
KOKI3. Crystal structure of eEF1A (grey) with the set of eEF1A
residues corresponding to the set of KO3 mutations displayed in
magenta and KI3 mutations displayed in cyan (the two residues
present in both KO3 and KI3 are displayed in cyan) (Color figure
online)
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dominates divergence among EF proteins. The KnockIn
variants also had subtle decreases in their abilities to bind
eEF1B. We suspect this diminished binding may have
occurred due to the two sites that overlapped between the
KI and KO variants despite the fact that the nucleotide
exchange factors generally bind in different regions
between the bacterial and eukaryotic EFs (compare struc-
tures in Fig. 2a, b, see Supplementary Figures S1–3 for a
list of sites).
Figure 2c reveals some epistatic effects observed in the
KnockOut-KnockIn combined variants. The KOKI variants
displayed an enhanced ability to bind EF-Ts compared to
the KI variants. This was an unexpected result because the
KO variants did not have any ability to bind EF-Ts thus we
would expect KOKI to have similar properties as KI. We
have not fully addressed this difference but it does suggest
that these KOKI sites have epistatic effects capable of
enhanced binding to EF-Ts. Alternatively, the KOKI
variants display similar diminished binding to eEF1B as
the KO variants. This suggests that the combination of KO
and KI sites had neither additive nor epistatic effects in
regards to eEF1B binding.
To determine whether our selection of sites potentially
biased the binding assays in the sense that we only focused
on sites within 5 A˚ of their respective nucleotide exchange
factors, a control eEF1A variant (eEF1A_C) was generated
in which sites not displaying functional divergence but that
fall within 5 A˚ of where EF-Ts would bind to eEF1A were
selected and the E. coli EF-Tu residues were integrated into
the yeast eEF1A protein. This eEF1A variant contained 17
residues from E. coli EF-Tu but still did not have any
measurable binding activity to EF-Ts (Supplementary
Figure S4). Thus, sites within the 5 A˚ cutoff itself were not
sufficient to generate EF-Ts binding and thus highlights the
importance of signals of heterotachy for efficient identifi-
cation and manipulation of functional divergence.
The above results validate the connection between sig-
nals of heterotachy at the sequence level to binding inter-
actions at the protein-level. The results do not, however,
allow us to determine whether any particular function has
been interchanged between EFs as it relates to protein
translation. For instance, the abilities of variants KI3 and
KOKI3 to bind EF-Ts does not necessarily indicate that
these two eEF1A variants now have analogous function-
alities as EF-Tu.
We exploited a reconstituted in vitro protein translation
system to address the functionality of these two eEF1A
variants. This system is composed of recombinant E. coli
biomolecules sufficient for in vitro translation (Shimizu et al.
2001). Such control of the system allows us to add/omit
particular components. As such, the eEF1A variants could be
added to the system in lieu of E. coli EF-Tu. Figure 3 dem-
onstrates that both eEF1A variants KI3 and KOKI3 were able
to participate significantly better in translation than the KO3
variant and the yeast wild-type eEF1A. Both KI3 and KOKI3
were able to bind EF-Ts (Fig. 2b, c) but the translation assay
demonstrates that these variants have been engineered with
the ability to actually participate in translation with bacterial
components. It is curious that KOKI3 does not participate in
translation as well as KI3 although the latter binds EF-Ts
more efficiently. We suspect this may be due, in part, to the
fact that these variants were soluble in different buffer sys-
tems. This may have affected the assays but additional
studies will be required to dissect the differences as well as
determine exactly how KI3 and KOKI3 are able to partici-
pate in translation while the other eEF1A proteins cannot.
Discussion
We have experimentally demonstrated for the first time that
particular patterns of functional divergence at the sequence
Fig. 3 In vitro translation assay using wild-type eEF1A and the
KOKI variants. A total of 15 replicate datasets were used from two
independent protein purifications. Due to differences in protein
refolding among the eEF1A proteins, a final buffer with 500 mM urea
was used for the first round (with 1.3 mg of protein per reaction) and
125 mM urea for the second round (with 1 mg of protein per
reaction). eEF1A variant KO3 was only active in the higher of the
urea buffers, while KIKO3 was only active in the lower of the urea
buffers. Data were collected using only the appropriate buffers for
each of these two variants (6 replicates for KI3 and 9 replicates for
KOKI3). All other analyses included data from both buffers to
determine what, if any, affect the buffers have on the other variants
(giving a total of 15 replicates). CPM were first normalized to the
control reactions lacking any eEF1A protein and two data points were
removed as statistical outliers (p \ 0.05, Grubb’s test). Averages and
standard errors of the mean are shown in the graph for each variant
and * indicates significantly different from wild-type eEF1A at
p \ 0.05 while ** indicates significantly different at p \ 0.01 using a
student’s one-tailed t test. Results are shown relative to a background
reaction lacking EF protein
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level (specifically, heterotachy/Type-I and Type-II) are
directly responsible for functional differences at the protein
level between homologous proteins from bacteria and
eukaryotes. This study provides a greater understanding of
the molecular constraints that give rise to certain patterns
identified using tools from the field of molecular evolution
(Benner and Gaucher 2001; Levasseur et al. 2006; Liberles
et al. 2012; Pagel and Meade 2008; Penn et al. 2008;
Rasmussen and Kellis 2007; Studer and Robinson-Rechavi
2010; Wertheim et al. 2012; Whelan et al. 2011). In the near-
term, our ability to connect heterotachous patterns to dif-
ferent levels of selection will be necessary (Blanquart and
Lartillot 2008). For instance, heterotachous patterns may
arise based on co-evolutionary constraints that maintain
thermodynamic stability of a protein (Pollock et al. 2012). It
would be improper to invoke functional divergence per se
when heterotachous patterns arise under such a scenario.
Although it seems reasonable to conclude that functional
divergence explains heterotachous patterns among EFs, it
does raise the intriguing question as to how the patterns
arose in the first place (we know why they have been
maintained) – did adaptation shape the evolutionary tra-
jectory of these sequence patterns or did intra-protein
co-evolutionary biomolecular constraints guide EFs in a
domain of life (either bacteria or eukaryotic) down a par-
ticular sequence trajectory and then evolution ‘‘dealt’’ with
these sequence patterns which in turn gave rise to two
disparate exchange factors (EF-Ts and eEF1B)? Interest-
ingly, the EF family itself may provide insight between
these two scenarios. We elected to not pursue a detailed
analysis of the reciprocal set of experiments whereby we
swap nucleotide exchange factor binding in EF-Tu because
E. coli’s EF-Tu is inherently capable of binding yeast’s
eEF1B exchange factor in a partial manner (this is in
contrast to yeast’s eEF1A complete inability to bind
E. coli’s EF-Ts as shown earlier). This may represent a
type of vestigial property from when bacteria and eukary-
otes diverged more than 3.5 billion years ago and whereby
the ancestral EF was adapting toward or away from eEF1B
binding. And one assumption is that residual binding
between EF-Tu and eEF1B has not been fully purged due
to overlapping co-evolutionary constraints.
Future studies will also have to determine how the
strength of patterns of functional divergence at the
sequence level accurately describes real divergence at the
biomolecular level. The inclusion of sequences, phyloge-
netic accuracy, and models of molecular evolution neces-
sarily influence signals of functional divergence at the
sequence level. Some details of these signals are under-
stood from a phylogenetic and protein perspective
(Gaucher and Miyamoto 2005; Kolaczkowski and Thorn-
ton 2004; Liberles et al. 2012; Wang et al. 2011). However,
more details are required before we understand the
connection between sequence patterns and the biomolecu-
lar properties that selective or neutral forces shape as a
consequence of the patterns themselves (Pollock et al.
2012; Studer and Robinson-Rechavi 2010).
We anticipate that our results provide rigor to evolu-
tionary analyses and serve as a bridge between computa-
tional and experimental approaches. Additional studies will
need to be conducted to determine whether heterotachy is
widely associated with divergence at the biochemical level.
In the other direction, we anticipate that our approach is
useful to the synthetic biology field since we were able to
create a chimeric protein endowed with expanded func-
tionalities simply based on evolutionary sequence patterns.
Such an approach could be exploited to generate synthetic
systems having novel properties. In doing so, this would
validate an evolutionary synthetic biology that combines
natural evolution with protein engineering principles (Cole
and Gaucher 2011a; Cole and Gaucher 2011b).
Materials and Methods
Bacterial Strains and Vectors
Tuner (DE3) pLysS competent cells (Novagen) were used
for protein expression. The pET-15b (Novagen) amino-
terminus His-tag vector was used for expression of the
nucleotide exchange factors eEF1B and EF-Ts. The pET-
21a (Novagen) carboxyl-terminus His-tag vector was used
for expression of EFs EF-Tu, eEF1A, and eEF1A variants.
The genes used in this study were synthesized by DNA2.0,
Inc. and Genewiz, Inc.
Expression and Purification of EF-Tu, EF-Ts,
and eEF1B
A single bacterial colony was inoculated into 3 mL of
Luria-Bertani (LB) media and incubated overnight at 37 C
with shaking. The overnight culture was diluted into a flask
containing 250 mL of fresh LB media, 100 lg/mL car-
benicillin, and 50 lg/mL chloramphenicol. The cells were
grown at 37 C to a density of 0.6 (A600) and then induced
at a final concentration of 1 mM Isopropyl b-D-1-thioga-
lactopyranoside (IPTG). The culture was incubated at
37 C for 4 h. The cells were collected by centrifugation at
4,5009g for 20 min. The wet weight of the pellet was
determined and stored at -80 C.
The frozen cells were thawed at room temperature for
15 min and re-suspended in BugBuster Protein Extraction
Reagent (Novagen). The cell pellet was completely
re-suspended using 5 mL BugBuster with 5 lL (25 units)
of Benzonase (Novagen) per gram of wet cell pellet. The
cell suspension was incubated on a shaking platform for
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30 min at room temperature. The insoluble cell debris was
removed by centrifugation at 10,000 9 g for 30 min at
4 C.
Ni–NTA columns were equilibrated with binding buffer
(50 mM NaH2PO4, 500 mM NaCl, 5 mM MgCI2, and
5 mM imidazole, pH 7.6). The cleared lysate was loaded
onto the equilibrated Ni–NTA column. The column was
washed five times with wash buffer (50 mM NaH2PO4,
500 mM NaCl, 5 mM MgCI2, and 50 mM imidazole, pH
7.6). The protein was eluted with elution buffer (50 mM
NaH2PO4, 500 mM NaCl, 5 mM MgCI2, and 500 mM
imidazole, pH 7.6). The purified protein was dialyzed
against 50 mM Tric-HCI (pH 7.8), 100 mM KCl, 1 mM
DTT, and 3 mM MgCI2. In all steps, the flow-through was
saved for analysis by SDS-PAGE to check the stringency
of the conditions.
Expression and Purification of eEF1A and Variants
The conditions for protein expression were identical as
above. However, the cells were induced at a final con-
centration of 0.5 mM IPTG and the frozen cells were
thawed at room temperature for 15 min and then re-
suspended in 8 M urea, 100 mM NaH2PO4, 5 mM MgCI2,
and 10 mM Tris–HCl (pH 8.0). Cell lysis was achieved by
sonication and the suspension was incubated on a shaking
platform for 2 h at room temperature. The cell debris was
removed by centrifugation at 10,0009g for 30 min at room
temperature.
The supernatant contained the denatured protein and was
transferred to a Ni–NTA column equilibrated with dena-
turing binding buffer (8 M urea, 10 mM NaH2PO4, 5 mM
MgCl2, and 10 mM Tris–HCl, (pH 8.0)). The column was
washed five times with 8 M urea, 100 mM NaH2PO4,
5 mM MgCI2, 10 mM Tris–HCl, and 50 mM imidazole
(pH 8.0). Elution occurred in 8 M urea, 100 mM NaH2PO4,
5 mM MgCI2, 10 mM Tris–HCl, and 300 mM imidazole
(pH 8.0). In all steps, the flow-through was saved for
analysis by SDS-PAGE to check the stringency of the
conditions.
Refolding Denatured-Purified Proteins
Denatured purified eEF1A protein (and variants) was
diluted two-fold in buffer consisting of 50 mM Tris–HCl,
20 mM NaCI, 100 mM KCI, (pH 8.2), and then stepwise
dialyzed against 2 M urea, 50 mM Tris-HCI, 20 mM
NaCI, 100 mM KCI, (pH 8.2); 1 M urea, 50 mM Tris-HCI,
20 mM NaCI, 100 mM KCI, (pH = 8.2); 150–500 mM
urea, 50 mM Tris-HCI, 20 mM NaCI, 100 mM KCI,
(pH = 8.2), respectively, using 20 kilodalton molecular
weight cut-off dialysis cassette (Thermo Scientific). Each
dialysis step lasted 12 h.
Removal of His-Tag from EF-Ts and eEF1B
The His-tag was removed from nucleotide exchange fac-
tors using thrombin (Novagen). Thrombin was diluted in
1:25 thrombin dilution buffer (50 mM sodium citrate pH
6.5, 200 mM NaCl, 0.1 % PEG-8000, 50 % glycerol) and
mixed with target protein and 10X thrombin cleavage
buffer (200 mM Tris–HCl, 1.5 M NaCl, 25 mM CaCl2,
(pH = 8.4)). The mixture was incubated at 25 C with
agitation for 16 h. Reactions were stopped with protease
inhibitor complex and incubated for 1 h. To clear all His-
tags and any potentially uncleaved His-tagged protein, the
reaction was loaded onto an equilibrated Ni–NTA column.
Flow-through was again passed over another equilibrated
Ni–NTA column to confirm that all flow-through was free
of His-tags. Samples were analyzed by SDS-PAGE and
confirmed that all His-tags were cleaved and removed from
the samples (Supplemental Figure S5).
Protein Quantification
Proteins used in binding assays were quantified by per-
forming Bradford protein assays. Each sample was mea-
sured in triplicate. One mL of Bradford solution (Bio-Rad)
was incubated at room temperature for 30 min and fol-
lowed by the addition of 20 lL of sample protein. After
5 min incubation at room temperature, samples were
transferred to a cuvette and absorption at 595 nm was
plotted against a bovine gamma globulin concentration
curve.
Pull-Down (Binding) Assay
His-tagged eEF1A and its variants were mixed with either
eukaryotic (eEF1B) or bacterial (EF-Ts) nucleotide
exchange factors (without His-tags) at a ratio of 1:1.5 and
incubated at room temperature for 4 h in an incubation
buffer of 55 mM Tris–HCl (pH 7.8), 130 mM KCl, 20 mM
NaCI, and 2 mM EDTA. Control reactions were performed
with wild-type EF-Tu and EF-Ts and with wild-type
eEF1A and eEF1B to confirm proper folding of all indi-
vidual reaction components. Before loading on a Ni–NTA
column, samples were diluted two-fold in incubation buffer
without EDTA. The dilution was done to prevent inter-
ference of EDTA with the column. The column was
washed twice with buffer A containing 55 mM Tris-HCI
(pH 8.2), 20 mM NaCI, 10 mM KCI, 500 mM urea, and
10 mM imidazole to remove nonspecific binding. Lastly,
samples were eluted with buffer B containing 55 mM Tris-
HCI (pH 8.2), 20 mM NaCI, 10 mM KCI, 500 mM urea,
and 500 mM imidazole and analyzed by SDS-PAGE.
The binding efficiencies of eEF1A and the variants were
determined by densitometric analyses using the ImageJ
10 J Mol Evol (2013) 76:4–12
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software package available from the National Institutes of
Heath. The percentage of total-lane intensity contributed
by the exchange factor band (EF-Ts or eEF1B) in each
binding assay was used as a metric to compare binding
efficiencies of eEF1A and the variants to the exchange
factors.
Statistical Analysis
DIVERGE software (Gu and Vander Velden 2002) was
used to detect functional divergence among EF protein
family members, based on site-specific rate shifts. A total
of 30 EF-Tu and eEF1A protein sequences and a phylo-
genetic tree from our previous work (Gaucher et al. 2001)
were analyzed. PP were calculated to determine whether a
site may have experienced heterotachy/Type-I or Type-II
patterns of divergence. As a test of robustness, we repeated
the analysis with an expanded set of sequences. We cal-
culated scores for Type-I and Type-II patterns using a set
of 50 eukaryotic and 50 bacterial sequences combined from
a set of phylogenetically diverse species. Of the 39 sites
identified as exhibiting robust levels of functional diver-
ence in our original analysis (Type-I sites having a cut-off
of 90 % and the top Type-II sites) we again identified all
but 5 of these sites. All 5 sites displayed a combination of
Type-I and Type-II functional divergence that confounded
the algorithms’ abilities to call the site as either Type-I or
Type-II.
Pymol software was used to map the distribution of
heterotachy/Type-I and Type-II sites across the three-
dimensional structure of EF-Tu and eEF1A. In Pymol, the
1EFU (Kawashima et al. 1996) and 1F60 (Andersen et al.
2000) structures were aligned to identify sites that were
within 5 A˚ of the opposite nucleotide exchange factor (i.e.,
sites on eEF1A within 5 A˚ of EF-Ts when EF-Tu and
eEF1A bound to their respective exchange factors are
structurally aligned). Sites to mutate were selected based
on the DIVERGE analysis using parameters and cutoffs
described in the main text.
In Vitro Translation Reactions
Translation reactions were carried out using a customized
in vitro translation assay kit (PURExpress, New England
Biolabs, NEB), where the amino acids, tRNAs, and EF-Tu
are added separately to a mix containing the remaining
components necessary for translation. Reactions were in
6 lL total volume and contained 1 lL of solution A,
0.5 lL of amino acid mixture, 0.5 lL of tRNA, 1.3 lL
solution B (all of the aforementioned supplied by NEB),
then 0.1 lL of RNAse inhibitor (40,000 U/mL), 0.25 lL of
S-35 methionine (Perkin-Elmer NEG009T), 0.2 lL of
template DNA (250 ng/lL), and 1.95 lL of eEF1A
proteins were added (see Fig. 3 for protein concentrations).
A master mix of all the components minus the eEF1A
proteins was assembled on ice and then dispensed to
reaction tubes containing the eEF1A protein in its final
refolding buffer. Template DNA was supplied on a plasmid
containing a T7 promoter, ribosome binding site and a
short gene that codes the peptide MVEVRHHHHHH.
Reactions incubated for 3 h at 37 C and were terminated
by adding 50 lL of stop buffer (50 mM Tris–HCl pH 8.0,
300 mM NaCl, 5 mM bmercaptoethanol). Reactions were
then transferred to 0.2 micron spin columns containing
15 lL of Ni–NTA agarose and rotated at room temperature
for 1 h. Peptide product was collected after two washes
with stop buffer by a 15-min elution at room temperature
using 50 lL of 500 mM imidazole. 45 lL of the eluted
peptide product was added to 2 mL of scintillation fluid
and counts per minute (CPM) were measured.
Acknowledgments We thank the PURExpress team at New England
Biolabs (especially Corinna Tuckey, Dongxian Yue and Eric Cantor)
for their assistance in developing a customized translation system,
and Joshua Stern for assistance with computational analyses. E. A.
G. acknowledges support from NASA Exobiology, NASA Astrobi-
ology Institute, and Georgia Institute of Technology. E. C.
acknowledges support from the Turkey Ministry of National Edu-
cation for a fellowship. M. F. C acknowledges support from NIH
NRSA award 5F32GM095182 and in part by the Emory University
Fellowship in Research and Science Teaching (FIRST) program’s
NIH/NIGMS IRACDA grant number K12 GM000680-11. J. T. K.
acknowledges support from a GAANN predoctoral fellowship and
the Georgia Institute of Technology TI:GER program for a predoc-
toral fellowship.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
Abhiman S, Daub CO, Sonnhammer ELL (2006) Prediction of
function divergence in protein families using the substitution rate
variation parameter alpha. Mol Biol Evol 23:1406–1413
Andersen GR, Pedersen L, Valente L, Chatterjee I, Kinzy TG,
Kjeldgaard M, Nyborg J (2000) Structural basis for nucleotide
exchange and competition with tRNA in the yeast elongation
factor complex eEF1A:eEF1Balpha. Mol Cell 6:1261–1266
Benner SA, Gaucher EA (2001) Evolution, language and analogy in
functional genomics. Trends Genet 17:414–418
Bershtein S, Tawfik DS (2008) Ohno’s model revisited: measuring the
frequency of potentially adaptive mutations under various
mutational drifts. Mol Biol Evol 25:2311–2318
Blanquart S, Lartillot N (2008) A site- and time-heterogeneous model
of amino acid replacement. Mol Biol Evol 25:842–858
Cole MF, Gaucher EA (2011a) Exploiting models of molecular
evolution to efficiently direct protein engineering. J Mol Evol
72:193–203
J Mol Evol (2013) 76:4–12 11
123
Cole MF, Gaucher EA (2011b) Utilizing natural diversity to evolve
protein function: applications towards thermostability. Curr Opin
Chem Biol 15:399–406
Da L, Kumar VG, Tay A, Mamun AA, Ho WK, See A, Chan L (2002)
Run-to-run process control for chemical mechanical polishing in
semiconductor manufacturing. Proceedings of the 2002 Ieee
International Symposium on Intelligent Control: pp. 740–745
Felsenstein J, Churchill GA (1996) A Hidden Markov Model
approach to variation among sites in rate of evolution. Mol Biol
Evol 13:93–104
Fitch WM (1971) Rate of change of concomitantly variable codons.
J Mol Evol 1:84–96
Fitch WM, Markowitz E (1970) An improved method for determining
codon variability in a gene and its application to the rate of
fixation of mutations in evolution. Biochem Genet 4:579–593
Gaucher EA, Miyamoto MM (2005) A call for likelihood phyloge-
netics even when the process of sequence evolution is hetero-
geneous. Mol Phylogenet Evol 37:928–931
Gaucher EA, Miyamoto MM, Benner SA (2001) Function-structure
analysis of proteins using covarion-based evolutionary approaches:
elongation factors. Proc Natl Acad Sci U S A 98:548–552
Gaucher EA, Das UK, Miyamoto MM, Benner SA (2002a) The
crystal structure of eEF1A refines the functional predictions of
an evolutionary analysis of rate changes among elongation
factors. Mol Biol Evol 19:569–573
Gaucher EA, Gu X, Miyamoto MM, Benner SA (2002b) Predicting
functional divergence in protein evolution by site-specific rate
shifts. Trends Biochem Sci 27:315–321
Gu X (2001) Maximum-likelihood approach for gene family evolu-
tion under functional divergence. Mol Biol Evol 18:453–464
Gu X, Vander Velden K (2002) DIVERGE: phylogeny-based analysis
for functional-structural divergence of a protein family. Bioin-
formatics 18:500–501
Hillis DM, Bull JJ, White ME, Badgett MR, Molineux IJ (1992)
Experimental phylogenetics: generation of a known phylogeny.
Science 255:589–592
Huelsenbeck JP (2002) Testing a covariotide model of DNA
substitution. Mol Biol Evol 19:698–707
Kawashima T, Berthet-Colominas C, Wulff M, Cusack S, Leberman R
(1996) The structure of the Escherichia coli EF-Tu.EF-Ts complex
at 2.5 A resolution. Nature 379:511–518
Kolaczkowski B, Thornton JW (2004) Performance of maximum
parsimony and likelihood phylogenetics when evolution is
heterogeneous. Nature 431:980–984
Kolaczkowski B, Thornton JW (2008) A mixed branch length model
of heterotachy improves phylogenetic accuracy. Mol Biol Evol
25:1054–1066
Levasseur A, Gouret P, Lesage-Meessen L, Asther M, Asther M,
Record E, Pontarotti P (2006) Tracking the connection between
evolutionary and functional shifts using the fungal lipase/
feruloyl esterase A family. Bmc Evol Biol 6:92
Liberles DA, Teichmann SA, Bahar I, Bastolla U, Bloom J, Bornberg-
Bauer E, Colwell LJ, de Koning APJ, Dokholyan NV, Echave J,
Elofsson A, Gerloff DL, Goldstein RA, Grahnen JA, Holder MT,
Lakner C, Lartillot N, Lovell SC, Naylor G, Perica T, Pollock
DD, Pupko T, Regan L, Roger A, Rubinstein N, Shakhnovich E,
Sjolander K, Sunyaev S, Teufel AI, Thorne JL, Thornton JW,
Weinreich DM, Whelan S (2012) The interface of protein
structure, protein biophysics, and molecular evolution. Protein
Sci 21:769–785
Lockhart PJ, Steel MA, Barbrook AC, Huson DH, Charleston MA,
Howe CJ (1998) A covariotide model explains apparent
phylogenetic structure of oxygenic photosynthetic lineages.
Mol Biol Evol 15:1183–1188
Lopez P, Casane D, Philippe H (2002) Heterotachy, an important
process of protein evolution. Mol Biol Evol 19:1–7
Merlo LM, Lunzer M, Dean AM (2007) An empirical test of the
concomitantly variable codon hypothesis. Proc Natl Acad Sci U
S A 104:10938–10943
Miyamoto MM, Fitch WM (1995) Testing the covarion hypothesis of
molecular evolution. Mol Biol Evol 12:503–513
Pagel M, Meade A (2008) Modelling heterotachy in phylogenetic
inference by reversible-jump Markov chain Monte Carlo. Philos
Transact R Soc B Biol Sci 363:3955–3964
Penn O, Stern A, Rubinstein ND, Dutheil J, Bacharach E, Galtier N,
Pupko T (2008) Evolutionary modeling of rate shifts reveals
specificity determinants in HIV-1 Subtypes. Plos Comput Biol
4(11):e1000214
Pollock DD, Thiltgen G, Goldstein RA (2012) Amino acid coevo-
lution induces an evolutionary Stokes shift. Proc Natl Acad Sci
USA 109:E1352–E1359
Pupko T, Galtier N (2002) A covarion-based method for detecting
molecular adaptation: application to the evolution of primate
mitochondrial genomes. Proc R Soc Lond Ser B Biol Sci
269:1313–1316
Rasmussen MD, Kellis M (2007) Accurate gene-tree reconstruction
by learning gene- and species-specific substitution rates across
multiple complete genomes. Genome Res 17:1932–1942
Roure B, Philippe H (2011) Site-specific time heterogeneity of the
substitution process and its impact on phylogenetic inference.
Bmc Evol Biol 11:17
Shimizu Y, Inoue A, Tomari Y, Suzuki T, Yokogawa T, Nishikawa K,
Ueda T (2001) Cell-free translation reconstituted with purified
components. Nat Biotechnol 19:751–755
Siltberg J, Liberles DA (2002) A simple covarion-based approach to
analyse nucleotide substitution rates. J Evol Biol 15:588–594
Studer RA, Robinson-Rechavi M (2010) Large-scale analysis of
orthologs and paralogs under covarion-like and constant-but-
different models of amino acid evolution. Mol Biol Evol
27:2618–2627
Tuffley C, Steel M (1998) Modeling the covarion hypothesis of
nucleotide substitution. Math Biosci 147:63–91
Wang HC, Spencer M, Susko E, Roger AJ (2007) Testing for
covarion-like evolution in protein sequences. Mol Biol Evol
24:294–305
Wang HC, Susko E, Roger AJ (2011) Fast statistical tests for
detecting heterotachy in Protein Evolution. Mol Biol Evol
28:2305–2315
Wertheim JO, Fourment M, Pond SLK (2012) Inconsistencies in
estimating the age of HIV-1 subtypes due to heterotachy. Mol
Biol Evol 29:451–456
Whelan S, Goldman N (2001) A general empirical model of protein
evolution derived from multiple protein families using a
maximum-likelihood approach. Mol Biol Evol 18:691–699
Whelan S, Blackburne BP, Spencer M (2011) Phylogenetic substi-
tution models for detecting heterotachy during plastid evolution.
Mol Biol Evol 28:449–458
Woods R, Schneider D, Winkworth CL, Riley MA, Lenski RE
(2006) Tests of parallel molecular evolution in a long-term
experiment with Escherichia coli. Proc Natl Acad Sci U S A
103:9107–9112
Wu JH, Susko E (2011) A test for heterotachy using multiple pairs of
sequences. Mol Biol Evol 28:1661–1673
Yang Z (1994) Maximum likelihood phylogenetic estimation from
DNA sequences with variable rates over sites: approximate
methods. J Mol Evol 39:306–314
Yang Z, Rannala B (2012) Molecular phylogenetics: principles and
practice. Nat Rev Genet 13:303–314
12 J Mol Evol (2013) 76:4–12
123
